Our Mission
To enhance the patient vaccination experience by commercializing an oral vaccine delivery system called QYNDR (pronounced kinder).
Aim to provide the industry with new technologies that stabilize more conventional vaccines, thereby increasing their shelf life and making less stable technologies, such as mRNA and Cold-Chain dependent drugs, more accessible and affordable.
What We Offer
Oral vaccine
Non-invasive, painless, a kinder vaccine experience.
Greater Protection
Delivers both the IgA - mucosal and the IgG - blood serum antibodies, offering greater protection from diseases.
Affordable Distribution
No expensive Cold Chain distribution or professional healthcare administration.
What is QYNDR?
QYNDR is an oral mucosal vaccine delivery platform that can be tailored to any number of vaccine targets, for ease of access, administration, and effectiveness over traditional vaccines. QYNDR also enables traditional vaccines to be modified so they can be taken orally, making for a non-invasive and painless experience, thus making it particularly well-suited for children.
Additionally, QYNDR is easily absorbed and provides lasting protection for the immune system. Overall, QYNDR offers a convenient and gentle approach to vaccination.
Why is QYNDR a kinder vaccine?
QYNDR is considered a kinder vaccine due to its ease of access, administration, and effectiveness. It can be taken orally, making it non-invasive and painless, which makes it particularly well-suited for children.
Additionally, QYNDR is easily absorbed and provides lasting protection for the immune system. Overall, QYNDR offers a convenient and gentle approach to vaccination.
Year cGMP
Completed sponsored Phase I human clinical trial for oral COVID vaccine
Provides clinical contracted materials
CCM support for 11 human clinical trial
The Challenge With Vaccines
- Vaccine distribution systems remain inadequate and expensive to scale
- Required trained professionals in clinics
- Patent aversion to injections
- Lack of trust in the safety, quality, and efficacy of vaccines
The QYNDR (Kinder) Solution
The QYNDR oral vaccine solves many challenges in scaling vaccination efforts to large global populations.
- QYNDR can be stored at stable temperatures (5-35℃)
- The QYNDR oral vaccine can be simply mailed to patients on a periodic basis
- No healthcare center or trained professionals required
- No expensive Cold Chain distribution required
